Global Adhesion Barrier Market Size, Trends & Analysis - Forecasts to 2026 By Type (Synthetic Adhesion Barriers [Hyaluronic Acid, Regenerated Cellulose, Polyethylene Glycol, and Other Synthetic Adhesion Barriers], Natural Adhesion Barriers [Collagen & Protein, and Fibrin]); By Delivery Mode (Film Formulations, Gel Formulations, and Liquid Formulations); By Application (Gynecological Surgeries, General/Abdominal Surgeries, Orthopedic Surgeries, Cardiovascular Surgeries, Neurological Surgeries, Urological Surgeries, Reconstructive Surgeries, and Other Surgeries); By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Vendor Landscape, and Company Market Share Analysis & Competitor Analysis
Adhesion Barrier Market Insights
As per the studies performed by GME, the adhesion barrier market will register significant growth at a CAGR of 8.12% within the conjecture span of 2020-2026. Adhesion barrier is a medical implant made up of physical film, gels, fabrics, or other materials, applied at the incision site between the layer of tissues undergone surgery. In some cases, it acts as a physical barrier for the separation of traumatized tissues to avoid tissue adhesion during tissue surface healing. Adhesion barriers include a broad surgical spectrum such as neurological surgeries, gynecological surgeries, urological surgeries, cardiovascular surgeries, reconstructive surgeries, general/abdominal surgeries, and orthopedic surgeries among others. As there is no effective drug for the prevention of surgical adhesion therefore adhesion barriers are the most exclusive solution for reduction or prevention of severity, incidence, extend, and repercussion of post-surgery adhesion.
Increasing surgery cases primarily cardiovascular surgeries have triggered the global adhesion market in past few years. Also, the growing age-old population is extensively supporting postoperative surgical complications risk thus widening the target range of the adhesion barrier market.
Healthcare improvement and involvement of multinational firms towards synthetic adhesive barrier with bio-absorbable properties and cost-effectiveness is expected to show a huge business in the coming years.
Several risks are associated with post-surgical adhesions in different surgeries such as abnormal pain, infertility after gynecological surgeries in women, and physical impairment after neurological surgeries. Even though many surgeons are reluctantly using the adhesives. However, due to the safety and efficacy issues of the products, it is very difficult for the companies to get market approval and thus affect the market penetration. COVID-19 has shown the most recent negative impact on the adhesion barrier market owing to the suspension of various operations.
Adhesion Barrier Market: By Type
By type, the market is segregated into synthetic adhesion barriers and natural adhesion barriers. The synthetic segment is further explained into hyaluronic acid, regenerated cellulose, and polyethylene glycol among others.
Synthetic adhesion barriers are the fastest-growing segment of the adhesive barrier market and dominated the revenue share of the 2019 market. Many national and international firms have adopted synthetic surgeries due to its bio-absorbable and biocompatible properties which eliminate the chance of another surgery for implant removal. Product affordability is another factor that supports the growth of the segment. However natural adhesion barrier is expected to show a moderate growth trend in the forecast period. Collagen, the sub-segment of the natural adhesion barrier builds the largest market in 2019 owing to product safety and durability properties.
Adhesion Barrier Market: By Delivery Mode
The delivery mode of the adhesive barrier can be divided into liquid formulations, film formulations, and gel formulations. A wide range of film formulations leads to build the largest adhesive market in the year 2019. Strong clinical safety and efficacy of the segment further adding values for the market growth. However, between the projected year, the safety of the gel segment is the prime boosters of the segment market in the coming years.
Adhesion Barrier Market: By Application
The application segment of the adhesive barrier is spilled into gynecological surgeries, general/abdominal surgeries, neurological surgeries, urological surgeries, orthopedic surgeries, cardiovascular surgeries, and reconstructive surgeries among others. Cardiovascular surgeries are predicted to show the fastest CAGR rate between the mentioned period. The high growth of heart-related disorder as a result of the change in lifestyle, heredity, or age are the prime reasons supporting the adhesion barrier market. Gynecological surgeries are the fastest business builder of the 2019 market on an account of the increasing percentage of gynecological laparoscopy procedures.
Adhesion Barrier Market: By Region
Raising the geriatric population with cardio and neurosurgeries is the primary cause of APAC being the fastest-growing region of the 2019 adhesion barrier market. Improvement in healthcare and awareness of the product in countries like India, China, and South Korea is propelling the demand for the product in the APAC region. Expansion of the private healthcare sector in underprivileged areas, epidemiological shifts to chronic disorders, and increase companies' investment towards launching new, cheap, and efficient technology are driving the demand for the product in the region.
Company Market Share and Competitor Analysis
The key players operating in the market include Johnson & Johnson, Baxter International, Becton, Dickinson and Company, Integra LifeSciences, Anika Therapeutics, Atrium Medical Corporation, FzioMed, MAST Biosurgery, Innocoll Holdings, Betatech Medical, CorMatrix Cardiovascular, Inc., Terumo Corporation, BiosCompass, and WL Gore & Associates among others.
Please note: This is not an exhaustive list of companies profiled in the report.
In July 2020, Anika Therapeutics launched a series of six products which will address orthopedic and sports medicine related surgeries. All six minimally invasive devices got FDA approval to encounter problems such as rotator cuffs repair, treat arthritis damage and, perform arthroscopic knee repair.
In July 2020, Baxter International received FDA approval for its next-generation bone graft product, Altpore bioactive bone graft. The product is designed so to improved bone growth and helps to achieve fusion to reduce pain and improve clinical outcomes.
Check the Press Release on Global Adhesion Barrier Market Report
We value your investment and offer free customization with every report to fulfil your exact research needs.
The Global Adhesion Barrier Market has been studied from the year 2017 till 2026. However, the CAGR provided in the report is from the year 2018 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply side analysis for the Adhesion Barrier Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the companies and customer analytics.
80% of our clients seek made-to-order reports. How do you want us to tailor yours?